KIN - Kindred Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Total Revenue
4,344
4,256
1,966
0
0
Cost of Revenue
4,072
587
324
-
-
Gross Profit
272
3,669
1,642
-
-
Operating Expenses
Research Development
30,025
28,310
26,399
17,665
13,861
Selling General and Administrative
36,898
37,926
26,499
13,988
8,308
Total Operating Expenses
66,923
66,236
52,898
31,653
22,169
Operating Income or Loss
-66,651
-62,567
-51,256
-31,653
-22,169
Total Other Income/Expenses Net
-
-
-
-
-655
Income Before Tax
-68,095
-61,389
-49,690
-30,879
-22,499
Income from Continuing Operations
-68,095
-61,389
-49,690
-30,879
-22,499
Net Income
-68,095
-61,389
-49,690
-30,879
-22,499
Net Income available to common shareholders
-68,095
-61,389
-49,690
-30,879
-22,499
Basic EPS
-
-
-1.60
-1.23
-1.13
Diluted EPS
-
-
-1.60
-1.23
-1.13
Basic Average Shares
-
-
31,001
25,084
19,873
Diluted Average Shares
-
-
31,001
25,084
19,873
EBITDA
-
-60,028
-50,451
-31,178
-22,014